Get started
Author

Domenico Penna

3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups
2019 · Natasha Szuber, Mythri Mudireddy, et al. · Mayo Clinic Proceedings · 168
Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger
2018 · Natasha Szuber, Rangit R. Vallapureddy, et al. · American Journal of Hematology · 98
PDF
Leukemic transformation among 1306 patients with primary myelofibrosis: risk factors and development of a predictive model
2019 · Rangit R. Vallapureddy, Mythri Mudireddy, et al. · Blood Cancer Journal · 75
PDF
Epidemiology, outcome, and risk factors for infectious complications in myelofibrosis patients receiving ruxolitinib: A multicenter study on 446 patients
2018 · Nicola Polverelli, Giuseppe A. Palumbo, et al. · Hematological Oncology · 57
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study
2021 · Carlo Visco, Luigi Marcheselli, et al. · Blood Advances · 55
PDF
3,023 Mayo Clinic Patients with Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups
2018 · Natasha Szuber, Mythri Mudireddy, et al. · Blood · 35
Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study⁎
2018 · Francesca Palandri, Giuseppe A. Palumbo, et al. · Seminars in Hematology · 31
Development of a prognostically relevant cachexia index in primary myelofibrosis using serum albumin and cholesterol levels
2018 · Ayalew Tefferi, Maura Nicolosi, et al. · Blood Advances · 26
Relapsed/refractory diffuse large B-cell lymphoma patients. A multicenter retrospective analysis of eligibility criteria for car-T cell therapy
2020 · Alice Di Rocco, Alice Di Rocco, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 19
SFLT‐1 levels in COVID‐19 patients: Association with outcome and thrombosis
2020 · Aurelio Negro, Angelo Fama, et al. · American Journal of Hematology · 18
20+ Years and alive with primary myelofibrosis: Phenotypic signature of very long‐lived patients
2018 · Domenico Penna, Terra L. Lasho, et al. · American Journal of Hematology · 14
PDF
Serum erythropoietin levels in essential thrombocythemia: phenotypic and prognostic correlates
2018 · Natasha Szuber, Sravanthi Lavu, et al. · Blood Cancer Journal · 12
PDF
Mutation-Enhanced International Prognostic Systems for Essential Thrombocythemia (MIPSS-ET) and Polycythemia Vera (MIPSS-PV)
2018 · Ayalew Tefferi, Paola Guglielmelli, et al. · Blood · 7
Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020
2023 · Lucia Mangone, Domenico Penna, et al. · Frontiers in Oncology · 5
PDF
New Horizons in Myeloproliferative Neoplasms Treatment: A Review of Current and Future Therapeutic Options
2021 · Domenico Penna · Medicina · 5
PDF
Cytogenetic clonal evolution in myeloproliferative neoplasms: contexts and prognostic impact among 648 patients with serial bone marrow biopsies
2019 · Ayalew Tefferi, Maura Nicolosi, et al. · Leukemia · 4
Mutations and Thrombosis in Essential Thrombocythemia and Polycythemia Vera: Mayo-Careggi Alliance Study
2018 · Paola Guglielmelli, Naseema Gangat, et al. · Blood · 2
The impact of sex on disease phenotype and prognostic thresholds of anemia in myelodysplastic syndromes
2018 · Domenico Penna, Maura Nicolosi, et al. · American Journal of Hematology · 2
Ruxolitinib: a new first-line strategy in autoimmune myelofibrosis treatment
2023 · Domenico Penna, Alessia Tieghi, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1
20+ Years and Alive with Primary Myelofibrosis: Phenotypic Signature of Very Long-Lived Patients
2018 · Domenico Penna, Maura Nicolosi, et al. · Blood · 1
The Germline JAK2 GGCC (46/1) Haplotype and Survival Among 414 Molecularly-Annotated Patients with Primary Myelofibrosis
2018 · Ayalew Tefferi, Terra L. Lasho, et al. · Blood · 1
Cytogenetic Clonal Evolution in Myeloproliferative Neoplasms: Contexts and Prognostic Impact Among 650 Patients with Serial Bone Marrow Biopsies
2018 · Maura Nicolosi, Domenico Penna, et al. · Blood · 1
Genetic predictors of response to specific drugs in primary myelofibrosis
2018 · Domenico Penna, Natasha Szuber, et al. · Blood Cancer Journal · 1
PDF
Remote Consultation in Primary Care During Emergencies
2025 · Domenico Penna, Maria Vittoria Dubbini, et al. · TELe-Health
Myeloproliferative Neoplasms in Young Patients: The Mayo Clinic Experience with 361 Cases Age 40 Years or Younger
2018 · Natasha Szuber, Mythri Mudireddy, et al. · Blood
Works count: 30
Citation count: 638
H-index: 12
I10-index: 12
Year
Topic
Type